Clinical trials
Active, not recruiting Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
216 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 18 |
| 2020 | 29 |
| 2021 | 37 |
| 2022 | 23 |
| 2023 | 27 |
| 2024 | 25 |
| 2025 | 13 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 216 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 13 |
| Memorial Sloan Kettering Cancer Center | 12 |
| National Cancer Institute (NCI) | 12 |
| H. Lee Moffitt Cancer Center and Research Institute | 6 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 |
| Massachusetts General Hospital | 5 |
| City of Hope Medical Center | 4 |
| Eli Lilly and Company | 3 |
| Jonsson Comprehensive Cancer Center | 3 |
| Mayo Clinic | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 216 |
| Colorectal Neoplasms | 33 |
| Stomach Neoplasms | 30 |
| Ovarian Neoplasms | 28 |
| Carcinoma, Non-Small-Cell Lung | 25 |
| Breast Neoplasms | 23 |
| Neoplasm Metastasis | 22 |
| Colonic Neoplasms | 19 |
| Lung Neoplasms | 19 |
| Esophageal Neoplasms | 17 |
Trials
Showing 1 to 25 of 216. Each trial links to its page on Pharma Observatory.
116 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.